Product Information
TAMSULOSIN HCL 0.4 MG CAPSULE is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0500 per EA under NDC 33342015944. Its NADAC has been published 386 times since May 15, 2019.
FDA first approved this application on Jan 20, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.4 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342015944
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TAMSULOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204645FDA Approved
1/20/2017
TE Code
AB
On Market Since
1/25/2017
Pharmacological Classes
Price Statistics
The NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has been published 386 times since May 15, 2019, and over the history we have for it it has declined 39.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0500 per EA |
|---|---|
| All-time high | $0.0931 (Sep 11, 2019) |
| All-time low | $0.0435 (Nov 20, 2024) |
| 52-week high | $0.0522 |
| 52-week low | $0.0494 |
| Median price | $0.0584 |
| Average price | $0.0614 |
| Largest weekly change | -19.3% (Apr 17, 2024) |
| Weeks tracked | 386 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tamsulosin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAMSULOSIN HCL 0.4 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TAMSULOSIN HCL 0.4 MG CAPSULE, manufactured by Macleods Pharmaceuticals Limited, is $0.0500 per EA (NDC 33342015944), effective Sep 30, 2026.
How has the price of TAMSULOSIN HCL 0.4 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has declined 39.8%. It has been tracked across 386 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for TAMSULOSIN HCL 0.4 MG CAPSULE?
Since May 15, 2019, the NADAC for TAMSULOSIN HCL 0.4 MG CAPSULE has ranged from a low of $0.0435 (Nov 20, 2024) to a high of $0.0931 (Sep 11, 2019), with a median of $0.0584 per EA.
Are there cheaper alternatives to TAMSULOSIN HCL 0.4 MG CAPSULE?
12 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TAMSULOSIN HCL 0.4 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures TAMSULOSIN HCL 0.4 MG CAPSULE?
TAMSULOSIN HCL 0.4 MG CAPSULE (NDC 33342015944) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.